Asia-Pacific Pharmacogenetics Testing in Psychiatry Market Set to Rise with Personalized Medicine Adoption
" According to the latest report published by Data Bridge Market Research, the Asia Pacific Pharmacogenetics Testing in Psychiatry/Depression Market  CAGR Value The Asia-Pacific pharmacogenetics testing in psychiatry/depression market was valued at USD 250.90 million in 2025 and is projected to reach USD 561.74 million by 2033, growing at a CAGR of 10.6% from...
0 Commentarios 0 Acciones 27 Views 0 Vista previa